Research map: Intravenous Lidocaine Does Not Provide Additional Pain Reduction Beyond Placebo in Probable Nociplastic Chronic Low Back Pain: A Randomized Controlled Trial- An Infographic

Back to the article

Papers in this map

  1. Intravenous Lidocaine Does Not Provide Additional Pain Reduction Beyond Placebo in Probable Nociplastic Chronic Low Back Pain: A Randomized Controlled Equivalence Trial · Subrata Pahari · 2026 · 1 citation · Cited by this paper
  2. Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine · 2026 · Related
  3. Shrinking pipelines and shifting priorities: an analysis of the 2019-2025 pain medicine fellowship match · 2026 · Related
  4. Preoperative guidance and an adolescent’s surgical recovery experience: a qualitative study · 2026 · Related
  5. Cumulative exposure and cardiovascular risk: predictors of serious adverse outcomes following long-term intravenous lidocaine therapy for chronic pain · 2026 · Related
  6. Response to LTE: CMS proposed restrictions on peripheral nerve blocks and procedures for chronic pain: clinical, ethical, and policy implications for millions of Americans · 2026 · Related
  7. Integrated nurse care management to reduce pain interference for primary care patients in rural communities: results from a pilot study · 2026 · Related
  8. Substance-related disorders in patients with chronic migraine: an exploratory, observational study · 2026 · Related
  9. Ultrasound and magnetic resonance imaging identification of postoperative ilioinguinal neuropathy · 2026 · Related
  10. Onboarding and retaining advanced practice providers in pain management: a call for practice management recommendations · 2026 · Related

Source: OpenAlex (CC0)